论文部分内容阅读
目的:探讨胸腔内注药治疗结核性胸膜炎临床疗效。方法:301例结核性胸膜炎患者,A组101例,胸腔内不注药;B组100例,胸内注入生理盐水10 ml、异烟肼针0.1~0.2 g,丁胺卡那霉素针0.1~0.2 g,地塞米松针5 mg;C组100例,在B组基础上胸内再注入山莨菪碱针20~30 mg,尿激酶20万IU。结果:三组中抽液次数、胸液吸收时间、胸膜厚度变化情况C组有显著疗效。结论:胸腔内注药治疗结核性胸膜炎临床疗效显著,值得进一步研究应用。
Objective: To investigate the clinical effect of intrathoracic injection in the treatment of tuberculous pleurisy. Methods: A total of 301 patients with tuberculous pleurisy were enrolled in this study. Group A (n = 101) had no intrathoracic injection. Group B (n = 100) received thoracic injection of 10 ml of normal saline, isoniazid needle 0.1-0.2 g, amikacin 0.1 ~ 0.2 g, dexamethasone needle 5 mg; C group 100 cases, on the basis of group B intrathoracic injection of anisodamine needle 20 ~ 30 mg, urokinase 200 000 IU. Results: There were significant curative effects in group C with the number of pumping fluid, the time of absorbing pleural fluid and the change of pleural thickness in three groups. Conclusion: Thoracic injection of tuberculous pleurisy clinical efficacy is significant, worthy of further study and application.